Phase II study of amonafide in gastric adenocarcinoma
- 1 September 1994
- journal article
- clinical trial
- Published by Springer Nature in Investigational New Drugs
- Vol. 12 (3) , 267-270
- https://doi.org/10.1007/bf00873971
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Phase I study of amonafide dosing based on acetylator phenotype.1993
- Paradoxical relationship between acetylator phenotype and amonafide toxicityClinical Pharmacology & Therapeutics, 1991
- Phase I clinical investigation of amonafide.Journal of Clinical Oncology, 1989
- Phase I clinical investigation of benzisoquinolinedione.1987
- PHARMACOKINETICS AND METABOLISM OF THE ANTITUMOR DRUG AMONAFIDE (NSC-308847) IN HUMANS1987
- Reporting results of cancer treatmentCancer, 1981